AI helps predict which DCIS patients need to be upstaged

A team led by Rui Hou, PhD, from Duke University found that AI based on mammography radiomics is superior to using models trained in clinical criteria alone.

“This suggests potential to use imaging algorithms to improve patient care and assist in the selection of patients for clinical trials,” Hou and colleagues said.

DCIS accounts for nearly 15% of all new breast cancer diagnoses. While DCIS on its own is not life-threatening, the study authors said these lesions could be precursors to invasive ductal carcinoma.

While it’s standard practice to surgically remove DCIS lesions, active…